Chapter 12 · Book Chapter
Open Access Peer Reviewed

Future Prospects and Emerging Trends in Cancer Nanomedicine

Dr. Chandrashekhar D. Patil1, Mr. Vitthal B. Kundgir2, Mr. Vijay V. Shewale3

Abstract

Cancer nanomedicine has emerged as a promising strategy for improving the selectivity, therapeutic efficacy, and safety of anticancer interventions. Conventional cancer treatments are often limited by non-specific drug distribution, systemic toxicity, multidrug resistance, and inadequate drug accumulation at tumor sites. Nanoparticle-based drug delivery systems offer opportunities to overcome these limitations through controlled drug release, enhanced tumor targeting, improved pharmacokinetic behavior, and the simultaneous delivery of multiple therapeutic agents. The future of cancer nanomedicine is increasingly focused on the development of intelligent, multifunctional, and patient-specific nanocarriers capable of responding to biological and pathological stimuli within the tumor microenvironment. Emerging platforms, including biomimetic nanoparticles, cell membrane-coated systems, exosome-inspired nanocarriers, biodegradable nanomaterials, and hybrid nanosystems, are expanding the therapeutic potential of nanotechnology. The integration of nanomedicine with artificial intelligence, machine learning, genomics, immunotherapy, gene therapy, and advanced imaging is expected to facilitate the rational design of precision drug delivery systems and improve treatment personalization. Furthermore, theranostic nanoparticles capable of integrating diagnosis and therapy may support real-time monitoring of disease progression and therapeutic response. Despite substantial progress, challenges related to biological heterogeneity, nanoparticle safety, large-scale manufacturing, reproducibility, regulatory evaluation, and clinical translation remain significant. This chapter discusses the emerging trends, technological innovations, translational challenges, and future opportunities shaping the next generation of cancer nanomedicine.

Cancer nanomedicineNanoparticle-mediated drug deliveryPrecision oncologyArtificial intelligenceSmart nanocarriersTheranosticsClinical translation

Author Affiliations

  • 1 Associate Professor, Department of Pharmacology, Divine College of Pharmacy, Satana, Nashik, Maharashtra.
  • 2 Lecturer, Department of Pharmacology, Divine College of Pharmacy, Satana, Nashik, Maharashtra.
  • 3 Assistant Professor, Department of Pharmacognosy, Divine College of Pharmacy, Satana, Nashik, Maharashtra.

How to Cite this Chapter

Patil, C. D., Kundgir, V. B., & Shewale, V. V. (2026). Future Prospects and Emerging Trends in Cancer Nanomedicine. In S. M. Ahire, P. S. Pawar, V. V. Shewale, & S. P. Jadhav (Eds.), Nanoparticle Mediated Drug Delivery Systems for Cancer Treatment: Advanced Nanotechnological Approaches in Targeted Cancer Therapy (pp. 284–310). WiseLeaf Scientific Ventures. https://doi.org/10.66079/wiseleaf.nanoparticle-cancer-thematic.2026
Back to the full volume

Related WiseLeaf titles